AzTrials
AzTrials

Thoracic Aortic DissectionNCT05610462

Trial of Exercise in Aortic Dissection Survivors

A study testing Guided Exercise Training Program in people with Thoracic Aortic Dissection, run by The University of Texas Health Science Center, Houston at 3 sites in United States.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The primary objective of this study is to test the safety and mental health benefits of a guided exercise program for people who survived an acute aortic dissection. This study is designed to answer several questions: 1. Can supervised exercise improve confidence and mental health in dissection survivors?; 2. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Thoracic Aortic Dissection
What is being tested?
Guided Exercise Training Program
Could I receive a placebo?
No, everyone receives an active treatment
How many people
126 participants
Where
3 sitesUnited States
Study dates
28 Jan 2023to 31 Oct 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • -Patients who survived a thoracic aortic dissection (Type A or B) at least 3 months prior to study.

Who cannot join

  • Routine participation in > 150 minutes per week of moderate intensity exercises
  • Unable to attend at least one exercise training session in person
  • Uncontrolled hypertension: mean SBP > 160 mmHg at rest
  • Symptomatic aortic, coronary, or vascular disease
  • Unable to complete exercise circuit due to physical limitations, equipment, space, or time commitment
  • Do not own a treadmill or stationary cycle or have regular access to one at a gym.

Trial locations and contacts

3 sites in 1 country.

United States3 sites
  • University of Michigan

    Ann Arbor, Michigan, 48109-5852

  • University of Texas Health Science Center, Houston

    Houston, Texas, 77030

  • Washington University in St. Louis

    St Louis, Missouri, 63130

Other trials in United States

About this study

Official title: A Multicenter Randomized Controlled Trial of Exercise in Aortic Dissection Survivors

The primary objective of this study is to test the safety and mental health benefits of a guided exercise program for people who survived an acute aortic dissection. This study is designed to answer several questions:

  1. Can supervised exercise improve confidence and mental health in dissection survivors?;
  2. How safe are different types of exercise for people who are living with severe aortic disease?;
  3. Can tests be developed to determine rational and safe limits to guide exercise recommendations for individual patients?;
  4. Does the blood pressure response to exercise predict risks for aortic enlargement or dissection in unique ways that other tests may not detect?
Read more

The long-term goal of this research is to develop new guidelines for exercise and daily activities that promote the safety and well-being of all TAD patients.

All participants will be required to:

  • Complete online questionnaires (demographic survey, 2009 Behavioral Risk Factor Surveillance Survey, the Patient-Reported Outcomes Measurement Information System 29 (PROMIS-29) v2.0 profile questionnaire)
  • Exercise (>150 minutes/week)
  • Receive all usual clinically indicated care, including diagnostic tests and medications. Recommendations for tests or interventions will not change based on the assigned study arm.

Participants who are randomized to guided exercise group will undergo initial training that consists of: one video demonstration, one exercise training session or group session, one follow up home visit, and virtual check-ins.

Participants who are randomized to usual care will attend routine clinic visits but will not receive any teaching or supervision and will not participate in any in-person or virtual exercise sessions. Instead, they will receive standardized counseling about exercise, including an exercise pamphlet that is given to all TAD patients.

Read the detailed description

Required number of study visits: 6 (3 in-person, 3 virtual)

Estimated total visit time per participant: 8 hours (guided exercise arm), 4 hours (control arm)

  • Visit 1 (Enrollment): After confirmation of eligibility and consent, participants will complete a demographic survey (age, sex, race, ethnicity) and the PROMIS-29 v2.0 profile questionnaire, which is validated to assess seven health domains (physical function, fatigue, pain, depressive symptoms, anxiety, ability to participate in social roles and activities, and sleep disturbance). Arterial pressure waveform and pulse wave velocity analysis will be performed (Sphygmocor, AtCor Medical, Inc.) and one set of orthostatic vital signs will be recorded (sitting x 3, lying, standing). Consent will also be obtained to extract additional outcome data from health records.
  • Visit 2 (Supervised training session): Participants will be fitted with ambulatory blood pressure monitors (ABPM, OnTrak, Space Labs, Inc.) and will complete an exercise circuit under the supervision of basic life support (BLS)-certified personnel. Participants will maintain each exercise at target intensity for at least 1 minute, or long enough to record at least one measurement. At steady state exertion, spotters will manually trigger OnTrak readings. Participants will pause between each exercise long enough to complete one ABPM reading (3 minutes). The circuit will be repeated once so that there will be two sets of measurements per exercise. Participants will rate their perceived level of exertion on a modified Borg scale.
  • In all cases, a spotter will brace the arm during ABPM measurements and ensure that pressures are recorded: Modified treadmill, wall sits, straight leg raises, bicep curls, hand grips with dynamometer at 40% maximum voluntary contraction (MVC) on the dominant arm.

Participants will then receive individualized instruction about how to implement this exercise protocol at home. The study team will promote a weekly target 5 days or at least 150 total minutes of exercise. Participants will complete a survey about where they intend to exercise (in their home or in a gym) and the type of equipment that they plan to use (a treadmill, a bicycle, or both). They will also be counseled to record their activities in an exercise diary. If they have a home blood pressure cuff or wearable device that can record fitness data, they will send the digital files to the study team at UTHealth. The instructional video and a diary template document will be emailed to all participants.

  • Visit 3 (Long Virtual Check-in): In the first month after enrollment, the study teams will conduct one video check-in with each participant to assess their home exercise setup, reinforce teaching about the exercise circuit, and answer questions about exercise. During the check-in, they will also observe and correct participants while they perform each exercise.
  • Visits 4 and 5 (Short Virtual Check-ins): Shorter video visits without exercise demonstrations will be repeated at 3 and 9 months after enrollment. These visits will be conducted in group sessions where participants will be encouraged to share their experiences with the exercise protocol and to troubleshoot potential obstacles to exercise. Participants will also transmit home blood pressure or fitness data to UTHealth if they are available. The study teams will promote the target of more than 150 minutes of moderate exercises per week at each interaction. All participants will also receive digital REDCap surveys about the intensity and frequency of their activities at 1, 3, and 9 months, and at the conclusion of the study. The content will be the same as the initial survey with an additional link to send messages directly to the study team.
  • Visit 6 (End of study visit): All study participants will undergo office blood pressure and Sphygmocor measurements and complete the same BRFSS activity and PROMIS-29 v2.0 questionnaires as at enrollment. They will be asked to wear an ABPM for 24 hours.
Being tested
Guided Exercise Training Program, Usual Care
Keywords
Thoracic Aortic Disease, Ambulatory Blood Pressure, Arterial stiffness, Aortic Dissection, Mental Health, Exercise
Medical subject headings
Dissection, Thoracic Aorta, Aortic Dissection, Psychological Well-Being, Motor Activity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Guided Exercise Training ProgramBehavioural

    The guided exercise program training consists of: a video demonstration, an exercise training session or group session, a follow up home visit, and virtual check-ins. The exercises include treadmill, wall sits, straight leg raise, bicep curls, hand grips with dynamometer at 40% maximal voluntary contraction (MVC), and Stationary cycling at moderate intensity (100 Watts).

  • Usual CareBehavioural

    Usual care consists of routine clinic visits and standardized counseling about exercise, including an exercise pamphlet that is given to all thoracic aortic dissection (TAD) patients.

Study groups in NCT05610462
Study groupRoleWhat they receive
Usual Care ControlActive comparatorParticipants who are randomized to usual care will attend routine clinic visits but will not receive any teaching or supervision and will not participate in any in-person or virtual exercise sessions. Instead, they will receive standardized counseling about exercise, including an exercise pamphlet that is given to all thoracic aortic dissection (TAD) patients.
Receives: Behavioral: Usual Care
Guided Exercise Training ProgramExperimentalParticipants who are randomized to the guided exercise group will undergo initial training that consists of: one video demonstration, one exercise training session or group session, one follow up home visit, and virtual check-ins.
Receives: Behavioral: Guided Exercise Training Program

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Number of participants with clinically important difference (CID) in the PROMIS-29 T score or the PROMIS mental health summary score

    The primary outcome is a clinically significant change in the PROMIS-29 T score or the PROMIS mental health summary score, a subset of PROMIS questions that primarily assess emotional distress (anxiety and depressive symptoms). The minimum clinically important difference (CID) is 5 points.

    Measured: Change from baseline PROMIS-29 T score at 12 months

Secondary outcomes (15)
  1. Change in office blood pressure

    The mean of three seated brachial measurements will be measured in the non-dominant arm.

    Measured: Change in office systolic and diastolic blood pressure at 12 months

  2. Change in daytime ambulatory hypertensive burden

    In 24 hour ambulatory blood pressures, the % of daytime systolic readings > 135 or diastolic readings > 80 mmHg

    Measured: Change in systolic and diastolic hypertensive burden by ABPM at 12 months

  3. Change in nighttime ambulatory hypertensive burden

    In 24 hour ambulatory blood pressures, the % of nighttime systolic readings > 120 or diastolic readings > 65 mmHg

    Measured: Change in systolic and diastolic hypertensive burden by ABPM at 12 months

  4. Prevalence of exertional hypertension

    Any systolic pressure > 180 mmHg, any diastolic pressure > 110 mmHg, or > 50 mmHg increase in systolic or diastolic pressures with exercise

    Measured: 1 month, at study visit 2

  5. Change in ambulatory nocturnal dipping

    In 24 hour ambulatory blood pressure, the % drop in mean nighttime pressures compared to mean daytime pressures.

    Measured: Change in nocturnal dipping by ABPM at 12 months

  6. Change in aortic augmentation index

    Aortic augmentation index will be measured using the Sphygmocor XCEL device

    Measured: Change in aortic augmentation index at 12 months

  7. Change in pulse wave velocity

    Carotid-femoral pulse wave velocity will be measured using the Sphygmocor XCEL device.

    Measured: Change in pulse wave velocity at 12 months

  8. Change in exercise minutes

    Minutes of moderate or high intensity exercise per week, as self-assessed by patients on BRFSS questionnaires

    Measured: Change in exercise minutes between study enrollment and 3 months, 9 months and 12 months.

  9. Change in grip strength

    Maximum grip strength as measured by dynamometer in Kg

    Measured: Change in grip strength at 12 months

  10. Change in antihypertensive medications

    Number of antihypertensive medications x total dosage in mg

    Measured: Change in antihypertensive medications at 12 months

  11. Total study time as a proportion of clinical time

    Logged time of all study-specific encounters divided by the estimated total time spent in clinically indicated interactions for TAD surveillance or treatment, ascertained from medical records

    Measured: 12 months

  12. Change in systolic blood pressure with exercise

    Measured: From baseline to end of study visit (12 months after baseline)

  13. Change in diastolic blood pressure with exercise

    Measured: From baseline to end of study visit (12 months after baseline)

  14. Post-guided exercise program heart rate

    Measured: Baseline

  15. Systolic blood pressure recovery times

    This is the time taken for the post work out blood pressure to get back to at least 10 percent of baseline blood pressure at enrollment

    Measured: Baseline

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Nov 2022
  2. Study start28 Jan 2023
  3. Primary completion31 Oct 2024 (estimated)
  4. Study completion31 Oct 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
126 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05610462
Sponsor's protocol ID
HSC-MS-22-0936
Status last verified
Apr 2024
First submitted
27 Oct 2022
Last updated
17 Apr 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Januzzi JL, Isselbacher EM, Fattori R, Cooper JV, Smith DE, Fang J, Eagle KA, Mehta RH, Nienaber CA, Pape LA; International Registry of Aortic Dissection (IRAD). Characterizing the young patient with aortic dissection: results from the International Registry of Aortic Dissection (IRAD). J Am Coll Cardiol. 2004 Feb 18;43(4):665-9. doi: 10.1016/j.jacc.2003.08.054.

    PubMed 14975480
  • Chaddha A, Eagle KA, Braverman AC, Kline-Rogers E, Hirsch AT, Brook R, Jackson EA, Woznicki EM, Housholder-Hughes S, Pitler L, Franklin BA. Exercise and Physical Activity for the Post-Aortic Dissection Patient: The Clinician's Conundrum. Clin Cardiol. 2015 Nov;38(11):647-51. doi: 10.1002/clc.22481.

    PubMed 26769698
  • Braverman AC. Medical management of thoracic aortic aneurysm disease. J Thorac Cardiovasc Surg. 2013 Mar;145(3 Suppl):S2-6. doi: 10.1016/j.jtcvs.2012.11.062. Epub 2012 Dec 20.

    PubMed 23260459
  • Milewicz DM, Prakash SK, Ramirez F. Therapeutics Targeting Drivers of Thoracic Aortic Aneurysms and Acute Aortic Dissections: Insights from Predisposing Genes and Mouse Models. Annu Rev Med. 2017 Jan 14;68:51-67. doi: 10.1146/annurev-med-100415-022956.

    PubMed 28099082
  • Milewicz D, Hostetler E, Wallace S, Mellor-Crummey L, Gong L, Pannu H, Guo DC, Regalado E. Precision medical and surgical management for thoracic aortic aneurysms and acute aortic dissections based on the causative mutant gene. J Cardiovasc Surg (Torino). 2016 Apr;57(2):172-7. Epub 2016 Feb 2.

    PubMed 26837258
  • Franz IW, Behr U, Ketelhut R. Resting and exercise blood pressure with atenolol, enalapril and a low-dose combination. J Hypertens Suppl. 1987 Aug;5(3):S37-41.

    PubMed 2822879
  • Virtanen K, Janne J, Frick MH. Response of blood pressure and plasma norepinephrine to propranolol, metoprolol and clonidine during isometric and dynamic exercise in hypertensive patients. Eur J Clin Pharmacol. 1982;21(4):275-9. doi: 10.1007/BF00637613.

    PubMed 7056271
  • Chen X, Hassan MO, Jones JV, Sleight P, Floras JS. Baroreflex sensitivity and the blood pressure response to beta-blockade. J Hum Hypertens. 1999 Mar;13(3):185-90. doi: 10.1038/sj.jhh.1000786.

    PubMed 10204815
  • Hamer M, Bauman A, Bell JA, Stamatakis E. Examining associations between physical activity and cardiovascular mortality using negative control outcomes. Int J Epidemiol. 2019 Aug 1;48(4):1161-1166. doi: 10.1093/ije/dyy272.

    PubMed 30541040
  • Gibson C, Nielsen C, Alex R, Cooper K, Farney M, Gaufin D, Cui JZ, van Breemen C, Broderick TL, Vallejo-Elias J, Esfandiarei M. Mild aerobic exercise blocks elastin fiber fragmentation and aortic dilatation in a mouse model of Marfan syndrome associated aortic aneurysm. J Appl Physiol (1985). 2017 Jul 1;123(1):147-160. doi: 10.1152/japplphysiol.00132.2017. Epub 2017 Apr 6.

    PubMed 28385916
  • Nakayama A, Morita H, Nagayama M, Hoshina K, Uemura Y, Tomoike H, Komuro I. Cardiac Rehabilitation Protects Against the Expansion of Abdominal Aortic Aneurysm. J Am Heart Assoc. 2018 Feb 27;7(5):e007959. doi: 10.1161/JAHA.117.007959.

    PubMed 29487112
  • Bartee S, Shrestha S, Ramos B, Bilbrey T, Carbone P, Schussler JM, Deutsch R, Adams J. Specificity of testing in a cardiac rehabilitation setting resulting in a patient's return to high-intensity outdoor activity following aortic dissection repair. Proc (Bayl Univ Med Cent). 2016 Apr;29(2):151-3. doi: 10.1080/08998280.2016.11929395.

    PubMed 27034550
  • Corone S, Iliou MC, Pierre B, Feige JM, Odjinkem D, Farrokhi T, Bechraoui F, Hardy S, Meurin P; Cardiac Rehabilitation working Group of the French Society of Cardiology. French registry of cases of type I acute aortic dissection admitted to a cardiac rehabilitation center after surgery. Eur J Cardiovasc Prev Rehabil. 2009 Feb;16(1):91-5. doi: 10.1097/HJR.0b013e32831fd6c8.

    PubMed 19237998
  • Ritchey MD, Maresh S, McNeely J, Shaffer T, Jackson SL, Keteyian SJ, Brawner CA, Whooley MA, Chang T, Stolp H, Schieb L, Wright J. Tracking Cardiac Rehabilitation Participation and Completion Among Medicare Beneficiaries to Inform the Efforts of a National Initiative. Circ Cardiovasc Qual Outcomes. 2020 Jan;13(1):e005902. doi: 10.1161/CIRCOUTCOMES.119.005902. Epub 2020 Jan 14.

    PubMed 31931615
  • Robicsek F, Thubrikar MJ. Hemodynamic considerations regarding the mechanism and prevention of aortic dissection. Ann Thorac Surg. 1994 Oct;58(4):1247-53. doi: 10.1016/0003-4975(94)90523-1.

    PubMed 7944800

Questions about this trial

What is this clinical trial studying?

A study testing Guided Exercise Training Program in people with Thoracic Aortic Dissection, run by The University of Texas Health Science Center, Houston at 3 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 17 Apr 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 3 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Number of participants with clinically important difference (CID) in the PROMIS-29 T score or the PROMIS mental health summary score (time frame: Change from baseline PROMIS-29 T score at 12 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05610462, which also lists 32 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Apr 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in